From Gut to Metabolism

医学 胰岛素抵抗 代谢综合征 疾病 肠道菌群 炎症性肠病 糖尿病 生物信息学 溃疡性结肠炎 炎症 脂肪组织 2型糖尿病 2型糖尿病 代谢紊乱 脂质代谢 免疫学 肥胖 全身炎症 血糖性 代谢组学 肝病 肾脏疾病 克罗恩病 碳水化合物代谢 微生物群 免疫系统 代谢途径 胰岛素 内科学
作者
Raseen Tariq,Richard K. Sterling,Anita Afzali,Arun J. Sanyal
出处
期刊:Journal of Clinical Gastroenterology [Lippincott Williams & Wilkins]
卷期号:60 (6): 480-489 被引量:1
标识
DOI:10.1097/mcg.0000000000002359
摘要

Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are chronic, relapsing inflammatory disorders increasingly recognized as systemic conditions with significant extraintestinal manifestations. Over the past 3 decades, the prevalence of IBD has risen in parallel with obesity and related metabolic disorders, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease (MASLD), and dyslipidemia. This parallel rise raises the possibility of shared or interacting biological pathways linking metabolic dysfunction and intestinal inflammation. Epidemiologic studies suggest increased risks of metabolic comorbidities in IBD independent of traditional factors, while mechanistic insights implicate systemic meta-inflammation, mesenteric adipose tissue remodeling (creeping fat), gut barrier dysfunction, and altered lipid and glucose metabolism. These pathways perpetuate a cycle of immune dysregulation and metabolic injury, amplifying disease severity and complications. Obesity and insulin resistance further impact IBD outcomes by altering pharmacokinetics and therapeutic response to biologics, with a higher body mass index associated with increased treatment failure, earlier loss of response, and heightened infection risk. Emerging data also suggest potential dual benefits of metabolic-directed therapies, such as glucagon-like peptide-1 receptor agonists, which may improve weight, glycemic control, and inflammatory indices. However, most evidence remains observational, with limited longitudinal or mechanistic studies. This narrative review synthesizes current knowledge at the interface of IBD and metabolic dysfunction, highlighting clinical implications, translational insights, and research gaps. Integrating metabolic screening and multidisciplinary management into IBD care may improve outcomes, while future mechanistic and interventional studies are needed to define therapeutic strategies that address both gut inflammation and systemic metabolic disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
杨羽完成签到,获得积分10
1秒前
tom发布了新的文献求助10
1秒前
流浪文献完成签到,获得积分10
1秒前
1秒前
2秒前
大白菜完成签到,获得积分10
2秒前
3秒前
暮谷完成签到,获得积分20
4秒前
lshlsh完成签到 ,获得积分10
4秒前
简单的大哥完成签到,获得积分10
4秒前
pokexuejiao发布了新的文献求助30
4秒前
搜集达人的应助被隐形冰之采纳,获得30
4秒前
hanbulashiga发布了新的文献求助10
5秒前
yuzu发布了新的文献求助10
5秒前
nagaaa完成签到,获得积分10
5秒前
香蕉觅云的应助被长情的凌旋采纳,获得10
5秒前
猪大肠呵呵完成签到,获得积分10
5秒前
体贴苠的应助被Gu0F1采纳,获得10
5秒前
充电宝的应助被yanghuikai采纳,获得10
5秒前
文嚓茶完成签到,获得积分10
6秒前
余舟唱晚关注了科研通微信公众号
6秒前
MrLiu完成签到,获得积分10
7秒前
日晖下浅浅的微笑完成签到,获得积分20
7秒前
luermei完成签到,获得积分10
7秒前
7秒前
orixero的应助被川里九樱采纳,获得10
7秒前
小拉卡咪发布了新的文献求助10
7秒前
情怀的应助被yu采纳,获得10
8秒前
8秒前
多多发布了新的文献求助10
9秒前
无花果的应助被菲菲采纳,获得10
9秒前
9秒前
苹果新竹完成签到,获得积分10
10秒前
10秒前
Akim的应助被qqqqqqqqqq采纳,获得50
10秒前
KayneJia完成签到,获得积分10
10秒前
FashionBoy的应助被大橙子采纳,获得10
11秒前
丘比特的应助被犹豫忆南采纳,获得10
11秒前
Jasper的应助被平平淡淡采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264